Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease

被引:10
作者
Black, P. N. [1 ]
McDonald, C. F. [2 ]
机构
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1142, New Zealand
[2] Austin Hosp, Inst Breathing & Sleep, Dept Resp & Sleep Med, Melbourne, Vic 3084, Australia
关键词
PNEUMOCOCCAL POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; DOUBLE-BLIND; PLACEBO; COPD; TIOTROPIUM; REHABILITATION; PREVENTION; MANAGEMENT; HOSPITALIZATION;
D O I
10.1136/pgmj.2008.072439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled beta agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 49 条
[1]   Counting, analysing and reporting exacerbations of COPD in randomised controlled trials [J].
Aaron, S. D. ;
Fergusson, D. ;
Marks, G. B. ;
Suissa, S. ;
Vandemheen, K. L. ;
Doucette, S. ;
Maltais, F. ;
Bourbeau, J. F. ;
Goldstein, R. S. ;
Balter, M. ;
O'Donnell, D. ;
FitzGerald, M. .
THORAX, 2008, 63 (02) :122-128
[2]   Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial [J].
Aaron, Shawn D. ;
Vandemheen, Katherine L. ;
Fergusson, Dean ;
Maltais, Francois ;
Bourbeau, Jean ;
Goldstein, Roger ;
Balter, Meyer ;
O'Donnell, Denis ;
McIvor, Andrew ;
Sharma, Sat ;
Bishop, Graham ;
Anthony, John ;
Cowie, Robert ;
Field, Stephen ;
Hirsch, Andrew ;
Hernandez, Paul ;
Rivington, Robert ;
Road, Jeremy ;
Hoffstein, Victor ;
Hodder, Richard ;
Marciniuk, Darcy ;
McCormack, David ;
Fox, George ;
Cox, Gerard ;
Prins, Henry B. ;
Ford, Gordon ;
Bleskie, Dominique ;
Doucette, Steve ;
Mayers, Irvin ;
Chapman, Kenneth ;
Zamel, Noe ;
FitzGerald, Mark .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :545-U15
[3]  
[Anonymous], 2006, COCHRANE DATABASE SY
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]   Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis [J].
Arandjus, Claire ;
Black, Peter N. ;
Poole, Phillippa J. ;
Baker, Richard Wood ;
Steurer-Stey, Claudia .
RESPIRATORY MEDICINE, 2006, 100 (10) :1671-1681
[6]   Theophylline - New perspectives for an old drug [J].
Barnes, PJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) :813-818
[7]   Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis [J].
Barr, R. G. ;
Bourbeau, J. ;
Camargo, C. A. ;
Ram, F. S. F. .
THORAX, 2006, 61 (10) :854-862
[8]   Antibiotics for the treatment of asthma [J].
Black, Peter N. .
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (03) :266-271
[9]   Reduction of hospital utilization in patients with chronic obstructive pulmonary disease -: A disease-specific self-management intervention [J].
Bourbeau, J ;
Julien, M ;
Maltais, F ;
Rouleau, M ;
Beaupré, A ;
Bégin, R ;
Renzi, P ;
Nault, D ;
Borycki, E ;
Schwartzmann, K ;
Singh, R ;
Collet, JP .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :585-591
[10]  
British Thoracic Society, 2006, BURD LUNG DIS REP